Ipca Laboratories Limited

NSE IPCALAB.NS

Ipca Laboratories Limited Goodwill for the year ending March 31, 2024: USD 10.86 M

Ipca Laboratories Limited Goodwill is USD 10.86 M for the year ending March 31, 2024, a 134.02% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

Ipca Laboratories Limited Goodwill for the year ending March 31, 2023 was USD 4.64 M, a -34.94% change year over year.
Ipca Laboratories Limited Goodwill for the year ending March 31, 2022 was USD 7.13 M, a 12.08% change year over year.
Ipca Laboratories Limited Goodwill for the year ending March 31, 2021 was USD 6.36 M, a -23.19% change year over year.
Ipca Laboratories Limited Goodwill for the year ending March 31, 2020 was USD 8.29 M, a 21.99% change year over year.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

NSE: IPCALAB.NS

Ipca Laboratories Limited

CEO	Mr. Pranay Premchand Godha
IPO Date	Jan. 1, 1996
Location	India
Headquarters	125, Kandivli Industrial Estate
Employees	17,335
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.

Key trends

Past 5 years